Strongly increased efficiency of altered peptide ligands by mannosylation

Author： Koning F.   Tan M.   Jordens R.   Geluk A.   Roep B.   Ottenhoff T.   Drijfhout J.  

Publisher： Oxford University Press

ISSN： 1460-2377

Source： International Immunology, Vol.10, Iss.9, 1998-09, pp. : 1299-1304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of CD25 + T cells secreting transforming growth factor‐1 by altered peptide ligands expressed as self‐antigens

By Yamashiro Hiromichi   Hozumi Nobumichi   Nakano Naoko  

International Immunology, Vol. 14, Iss. 8, 2002-08 ,pp. : 857-865

Oxford University Press

Access to resources Recommend Favorite

Altered Peptide Ligands of Islet Autoantigen Imogen 38 Inhibit Antigen Specific T Cell Reactivity in Human Type-1 Diabetes

By Geluk A.   van Meijgaarden K.E.   Roep B.O.   Ottenhoff T.H.M.  

Journal of Autoimmunity, Vol. 11, Iss. 4, 1998-08 ,pp. : 353-361

Academic Press

Access to resources Recommend Favorite

Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands

By Kuchroo V.  

International Immunology, Vol. 11, Iss. 3, 1999-03 ,pp. : 407-416

Oxford University Press

Access to resources Recommend Favorite

Peptide binding and editing: generation of TCR ligands

By Hammerling G.J.   Manoury B.   Watts C.   Adorini L.   Lanzavecchia A.  

Research in Immunology, Vol. 149, Iss. 9, 1998-11 ,pp. : 863-865

Elsevier

Access to resources Recommend Favorite

Molecular basis for the lack of T cell proliferation induced by an altered peptide ligand

By VanDyk L.  

International Immunology, Vol. 10, Iss. 7, 1998-07 ,pp. : 969-979

Oxford University Press

Access to resources Recommend Favorite